World Immunotherapy Congress

 

2-4 March 2020 | Loews Resort Coronado, San Diego

 

 

1000+
Attendees
500+
1-2-1 Meetings
300+
Speakers
70+
Exhibitors
3
Co-located events
 

Key Speakers in 2020

Andrew Allen, President & Chief Executive Officer, Gritstone Therapeutics Andrew Allen
President & CEO
Gritstone Therapeutics

Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics Bob Valamehr 
Vice President of Cancer Immunotherapy
Merck

Ira Mellman, Vice President, Caner Immunology, Genentech Brian Champion
CSO
PsiOxus Therapeutics

William Chou, Vice President, Global Commercial Disease Leader, Novartis Linda Liu
SVP, Research
NextCure

Roy Banes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp & Dohme Bob Valamehr
Chief Development Officer
Fate Therapeutics

Congress Topics

 

 

 

WHAT IS THE WORLD IMMUNOTHERAPY CONGRESS?

Networking


It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.

Conference


The World Immunotherapy Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

Exhibition

Exhibit at Work 2.0


This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.

 
 
 
 
 
 

Who Attends

 

AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart

 

 
 

Make sure you are at the forefront of the big pharma and biotech industry. No matter where your interest lies, at the Americas Antibody Congress, World Immunotherapy Congress USA and World Biosimilar Congress USA, we have content, networking and potential partners for you. 

Download the brochure to find out exactly what's in store for this year's event.

 

DOWNLOAD PROSPECTUS

 

Festibval of Biologics USA

 

There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.